GINGER HART: Open Payments
NPI 1750871570 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,344 in 58 payments from 11 companies in 2025. Trend: 2023 $1,270 · 2024 $1,637 · 2025 $2,344
Food & beverage: $1,274Travel & lodging: $1,062Education: $9
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 17 | $1,608 |
| Alnylam Pharmaceuticals Inc. | 11 | $209 |
| PFIZER INC. | 11 | $155 |
| Novartis Pharmaceuticals Corporation | 10 | $143 |
| Boston Scientific Corporation | 1 | $75 |
| BridgeBio Pharma, Inc. | 3 | $54 |
| ABIOMED | 1 | $31 |
| AtriCure, Inc. | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: LINQ II, AURORA EV-ICD MRI SURESCAN, AMVUTTRA, ELIQUIS, LEQVIO, General - Therapies, Attruby, ATRICLIP LAA EXCLUSION SYSTEM.
Industry payments across AR — which companies pay providers there.
